CAS RN: 193275-84-2
LONAFARNIB
Product Availability
Choose a grade to view its available package options.
9 package records 8 with current stock 2 grade groups
Grade
98% (8)
99% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250204
100mg
In stock
Shanghai Inquiry
Batchno.20250122
10mg
In stock
Shanghai Inquiry
Batchno.20260610
1g
Out of stock
Inquiry
Batchno.20250803
1mg
In stock
Shanghai Inquiry
Batchno.20250514
250mg
In stock
Shanghai, Shenzhen Inquiry
Batchno.20250403
25mg
In stock
Shanghai Inquiry
Batchno.20250803
50mg
In stock
Shanghai Inquiry
Batchno.20260130
5mg
In stock
Shanghai Inquiry
Batch No. Package Availability Warehouse Inquiry
Batchno.20251209
1mg / 5mg / 25mg / 100mg
Confirm by inquiry
Shanghai, Shandong, Chongqing Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 193275-84-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shanghai
Inquiry
193275-84-2 / 4-[2-[4-[(2R)-6,15-dibromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperidin-1-yl]-2-oxoethyl]piperidine-1-carboxamide
Standard CAS: 193275-84-2
Multi CAS: No
Basic Information
copy
CAS
193275-84-2 copy
Multi CAS
No copy
Molecular Formula
C27H31Br2ClN4O2 copy
Molecular Weight
638.800000 copy
Exact Mass
638.048180 copy
SMILES
C1CN(CCC1CC(=O)N2CCC(CC2)[C@@H]3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N copy
InChI
InChI=1S/C27H31Br2ClN4O2/c28-20-12-19-2-1-18-13-21(30)14-22(29)24(18)25(26(19)32-15-20)17-5-9-33(10-6-17)23(35)11-16-3-7-34(8-4-16)27(31)36/h12-17,25H,1-11H2,(H2,31,36)/t25-/m1/s1 copy
InChIKey
DHMTURDWPRKSOA-RUZDIDTESA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
36 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.52 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
148.14 copy
TPSA
79.53 copy
LogP / Solubility
WLOGP
5.91 copy
MLOGP
5.25 copy
XLogP3
4.8 copy
Consensus LogP
5.32 copy
Log S (ESOL)
-7.57 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-9.07 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-9.08 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.42 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Leadlikeness
No copy
Synthetic Accessibility
5.5 copy
Safety & Transport
copy
Pictogram(s)
Health Hazard copy
Signal
Warning copy
GHS Hazard Statements
H361 (91.7%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
H373 (91.7%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure] copy
Precautionary Statement Codes
P203, P260, P280, P318, P319, P405, and P501 copy